Evidence map›Paper›PMID 32500549›Full record

ReviewThe journal of obstetrics and gynaecology research2020

Clinical update on COVID-19 in pregnancy: A review article.

Gillian A Ryan, Nikhil C Purandare, Fionnuala M McAuliffe, Moshe Hod, Chittaranjan N Purandare

Open access · bronzeAbstract readReview
In one paragraph

Review in The journal of obstetrics and gynaecology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Maternal and Neonatal Outcomes in COVID-19-Positive Pregnant Women.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Gillian A RyanDepartment of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland.
Nikhil C PurandareDepartment of Obstetrics and Gynaecology, University Hospital Galway, Galway, Ireland.
Fionnuala M McAuliffeDepartment of Obstetrics and Gynaecology, The National Maternity Hospital, Dublin, Ireland.
Moshe HodMor Women Health Care Center, Tel Aviv University, Tel Aviv, Israel.
Chittaranjan N PurandareEmeritus Dean, Indian College of Obstetricians and Gynaecologists, Mumbai, India.
National Maternity Hospital · IETel Aviv University · ILUniversity Hospital Galway · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The data pertaining to the COVID-19 pandemic has been rapidly evolving since the first confirmed case in December 2019. This review article presents a comprehensive analysis of the current data in relation to COVID-19 and its effect on pregnant women, including symptoms, disease severity and the risk of vertical transmission. We also review the recommended management of pregnant women with suspected or confirmed COVID-19 and the various pharmacological agents that are being investigated and may have a role in the treatment of this disease. At present, it does not appear that pregnant women are at increased risk of severe infection than the general population, although there are vulnerable groups within both the pregnant and nonpregnant populations, and clinicians should be cognizant of these high-risk groups and manage them accordingly. Approximately 85% of women will experience mild disease, 10% more severe disease and 5% critical disease. The most common reported symptoms are fever, cough, shortness of breath and diarrhea. Neither vaginal delivery nor cesarean section confers additional risks, and there is minimal risk of vertical transmission to the neonate from either mode of delivery. We acknowledge that the true effect of the virus on both maternal and fetal morbidity and mortality will only be evident over time. We also discuss the impact of social isolation can have on the mental health and well-being of both patients and colleagues, and as clinicians, we must be mindful of this and offer support as necessary.

Indexed as

BetacoronavirusCoronavirus InfectionsCost of IllnessCOVID-19FemaleHumansInfant, NewbornInfectious Disease Transmission, VerticalMaternal MortalityMental HealthMorbidityPandemicsPneumonia, ViralPregnancyPregnancy Complications, InfectiousPrenatal Carecoronavirus and pregnancyCOVID-19 and breastfeedingCOVID-19 and pregnancy

Identifiers

PMID32500549
PMCPMC7300676
OpenAlexW3032893685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.